Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ALPINE 2: Aztreonam for Inhalation in Pediatric CF
NCT03219164Phase 3Terminated
- Sponsor
- Gilead Sciences
- Start
- Nov 2017
- Primary completion
- May 2020
- Modality
- Inhalation Devices, Small Molecules
- Countries
- 12
01
Overview
A Phase 3 trial of aztreonam in Pseudomonas aeruginosa infection, sponsored by Gilead Sciences. Started Nov 2017; status: terminated.
02
Drugs
aztreonam
03
Conditions
Pseudomonas aeruginosa infection
Beyond the preview
Go deeper on NCT03219164.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03219164.